The human fibrinolytic system
- 30 September 1996
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 24 (1) , 27-45
- https://doi.org/10.1016/1040-8428(96)00206-5
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Receptor‐mediated endocytosis of plasminogen activators and activator/inhibitor complexesFEBS Letters, 1994
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Platelet‐activating factor secreted by DDAVP‐treated monocytes mediates von willebrand factor release from endothelial cellsJournal of Cellular Physiology, 1993
- The plasminogen-plasmin system in malignancyCancer and Metastasis Reviews, 1992
- Fibrinolytic response during exercise and epinephrine infusion in the same subjectsJournal of the American College of Cardiology, 1992
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989
- Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and strokeThe American Journal of Cardiology, 1988
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasmaBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Human endothelial cells contain one type of plasminogen activatorFEBS Letters, 1984